Indivior Treatment Services, Inc. is a global pharmaceutical company dedicated to transforming the treatment landscape for substance use disorders (SUD), particularly in the context of the opioid crisis. With a vision that all patients worldwide have access to evidence-based treatments, Indivior focuses on developing innovative medicines and expanding its portfolio of opioid use disorder (OUD) treatments. The company is committed to eliminating the stigma surrounding addiction and engages with various stakeholders, including governments, healthcare professionals, and advocacy groups, to raise awareness and educate about addiction as a chronic disease. Indivior fosters a culture of integrity and collaboration, aiming to drive innovation in addiction treatment while providing a supportive environment for its employees.